Search
Moderna Inc
MRNAAdd to Watchlist
183.860USD
+10.920+6.31%
Market hours 09/22, 11:49（ET）
73.36BMarket Cap
LossP/E TTM
Moderna Inc (MRNA) Stock Price Target & Forecast
Analyst Rating
Based on 24 analysts giving stock ratings to Moderna Inc in the past month.
Hold
0 Strong Buy
4 Buy
17 Hold
2 Sell
1 Strong Sell
Target Price
112.068USD-27.25%
MRNA Analyst Recommendation Trends
In the current month, MRNA has received 4 Buy Ratings, 17 Hold Ratings, and 2 Sell Ratings. MRNA average Analyst price target in the last month is 112.068.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
4
4
4
3
3
3
4
4
17
17
17
19
19
19
17
16
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
24
24
24
25
25
25
25
24
MRNA Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, MRNA EPS is projected to reach -1.278 in FY2026Q3, following reported EPS of -1.965 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.64
-3.96
-2.08
-1.28
-1.75
Actual
-2.11
-3.40
-1.96
--
--
Surprise
+20.26%
+14.16%
+5.68%
--
--
FAQs
What is Moderna Inc's expected revenue for the next quarter?
Moderna Inc's expected revenue is 886.79M.
What is Moderna Inc's price target?
Analysts forecast that Moderna Inc's price target is USD 112.07, with the highest forecast at USD 170.00 and the lowest forecast at USD 40.00.
How have Moderna IncMRNA's recent earnings per share performed?
The market expectation was USD -1.96, while Moderna IncMRNA's earnings per share (EPS) for the previous quarter was USD -3.40. EPS for the next quarter is expected at USD -1.28.
What is the analyst rating for Moderna Inc?
Based on the ratings of Moderna Inc's stock from 24 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.